Training of early-staged researchers and experienced researchers involved in CanBioSe research works on nanomaterials processing and scientific seminar on Advances in nanomaterials research for biomedical applications, were held with invited experts - Prof. Yury Gogotsi (Drexel University, USA) and Prof. Alexander Pogrebnjak (Sumy State University, Ukraine) in the framework of H2020 MSCA RISE CanBioSe project, in Materials Research Center research premises, Kyiv, on July 30-August 01, 2020.
Read more about CanBioSe project
|
|
Horizon 2020 CANBIOSE project participant from MRC Ivan Hryshko completed secondment visit to Vilnius University, Lithuania, on February-March 2020
|
He made a presentation at a seminar to share knowledge and experience in MAX phase and MXene synthesis, received a training and also worked with colleagues from VU on nanomaterials characterization, all related issues were discussed with project participants from Vilnius University.|
|
Horizon 2020 CANBIOSE project participants from MRC visited partner organization Adam Mickiewicz University in Poznań, Poland, on October 27-November 27, 2019
|
In cooperation with AMU colleagues they were working on nanomaterials testing and characterization.|
|
CanBioSe project Meeting and Workshop atinternational Conference on Nanomaterials for biosensors and nanomedical applications in Yurmala, Latvia, July 2019
|
MRC representatives, Oleksiy Gogotsi and Veronika Zahorodna attended CanBioSe project meeting held during International Conference on Nanomaterials for biosensors and biomedical applications, Jurmala, Latvia, on July 2019.|
|
Project Meeting and Workshop under Horizon-2020 MSCA RISE CanBioSE project, 17-18 th of April 2019, Vilnius, Lithuania
|
Research team of Materials Research Centre led by Oleksiy Gogotsi take part in CanBioSe project meeting and Workshop held in Vilnius University, Vilnus, Lithuania. MRC team met with another CanBioSe project participants, presented MRC company. Also MRC director gave a talk on 2d materials MXenes and their possible applications.
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
